Celldex Therapeutics Inc (NASDAQ:CLDX)

39.67
Delayed Data
As of Dec 08
 +0.90 / +2.32%
Today’s Change
15.37
Today|||52-Week Range
57.20
+126.43%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Celldex Therapeutics Inc have a median target of 67.00, with a high estimate of 68.00 and a low estimate of 60.00. The median estimate represents a +68.89% increase from the last price of 39.67.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Celldex Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.42
Sales
$1.0M
Reporting Date
Mar 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 7.41%
 
 
 
 
 
 
Growthannually 18.81%
 
 
 
 
 
 

Sales

Growthquarterly 577.12%
 
 
 
 
 
 
Growthannually -28.01%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.